COVID-19 vaccine trials: Duty of care and standard of prevention considerations.

Singh, Jerome Amir

Singh, Jerome Amir.

Singh JA; CAPRISA, University of KwaZulu-Natal, Durban, South Africa; Department of Clinical Public Health, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada; Howard College School of Law, University of KwaZulu-Natal, King George V Ave, Durban 4001, South Africa. Electronic address: singhj9@ukzn.ac.za.

Vaccine ; 38(48): 7578-7580, 2020 11 10.

Article in English | MEDLINE | ID: covidwho-842901

Subject(s)

Coronavirus Infections/epidemiology; Coronavirus Infections/prevention & control; Pandemics/prevention & control; Personal Protective Equipment/supply & distribution; Pneumonia, Viral/epidemiology; Pneumonia, Viral/prevention & control; Risk Assessment; Viral Vaccines/administration & dosage; Betacoronavirus/immunology; Betacoronavirus/pathogenicity; COVID-19; COVID-19 Vaccines; Clinical Trials as Topic; Coronavirus Infections/immunology; Coronavirus Infections/virology; Drug Approval/legislation & jurisprudence; Humans; International Cooperation; Patient Safety; Personal Protective Equipment/ethics; Pneumonia, Viral/immunology; Pneumonia, Viral/virology; Practice Guidelines as Topic; SARS-CoV-2; Viral Vaccines/biosynthesis

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Viral Vaccines / Coronavirus Infections / Risk Assessment / Pandemics / Personal Protective Equipment Type of study: Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Humans Language: English Journal: Vaccine Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google